Olinding, Lolita M.

HRN: 05-06-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
CLINDAMYCIN 300MG (CAP)
06/10/2022
06/15/2022
ORAL
300 Mg
Q6
Infected Stump, Left
Waiting Final Action 

Indication:  Empirical De-escalation    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: